Furthermore, neuropathological studies clearly suggest that other proteinopathies, such as TDP-43 and alphasynuclein, likely contribute to cognitive decline in this age range (47, 48), but are currently lacking quantitative biomarkers that are easily obtained in vivo. This evidence concerns the gene SNCA and proteostasis deficiencies.